Effects of rapamycin on active Heymann nephritis

scientific article published on 13 June 2007

Effects of rapamycin on active Heymann nephritis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000103918
P698PubMed publication ID17570905

P50authorNevena Mihailović-StanojevićQ79454600
P2093author name stringTamara Aleksic
Gordana Basta-Jovanovic
Dijana Jovanovic
Radomir Naumovic
Djurdjica Jovovic
Zoran Miloradovic
P433issue4
P921main subjectsirolimusQ32089
P304page(s)379-389
P577publication date2007-06-13
P1433published inAmerican Journal of NephrologyQ15762667
P1476titleEffects of rapamycin on active Heymann nephritis
P478volume27

Reverse relations

cites work (P2860)
Q85964497AKT2 is essential to maintain podocyte viability and function during chronic kidney disease
Q42068754Calcium mediates glomerular filtration through calcineurin and mTORC2/Akt signaling
Q37760379Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases
Q41854722Rapamycin ameliorates proteinuria and restores nephrin and podocin expression in experimental membranous nephropathy.
Q38914374Roles of mTOR complexes in the kidney: implications for renal disease and transplantation.
Q36100123Understanding the mechanisms of proteinuria: therapeutic implications
Q37810461mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression

Search more.